awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46481747-86A200B5-831B-40AC-B869-2DD92BC9E9B4
Q46481747-86A200B5-831B-40AC-B869-2DD92BC9E9B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46481747-86A200B5-831B-40AC-B869-2DD92BC9E9B4
Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma.
P2860
Q46481747-86A200B5-831B-40AC-B869-2DD92BC9E9B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46481747-86A200B5-831B-40AC-B869-2DD92BC9E9B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
40b40dd7ac78f88f23bded943e39c5462bda1c2e
P2860
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.